MCM
GEN

Mazama Capital Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Mazama Capital Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-564,952
Closed -$1.96M – 205
2015
Q4 		$1.96M Buy
564,952
+132,230
+31% +$633K 0.36% 75
2015
Q3 		$2.65M Buy
432,722
+215,315
+99% +$1.46M 0.55% 54
2015
Q2 		$1.44M Sell
217,407
-6,628
-3% -$44.7K 0.29% 96
2015
Q1 		$1.59M Buy
+224,035
New +$1.69M 0.33% 94

Other funds holding GEN

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mazama Capital Management's GEN Position: Q1 2016 in Review

Mazama Capital Management sold out of Genesis Healthcare, Inc. (GEN) in Q1 2016, closing a stake of 564,952 shares — an estimated $1.96M sold.

Mazama Capital Management first reported a position in GEN in Q1 2015 and held it in 4 quarters. The position peaked at $2.65M in Q3 2015. 71 funds tracked by Wall St. Rank hold GEN as of Q1 2016.

  • Mazama Capital Management reported no remaining Genesis Healthcare, Inc. position as of Q1 2016 after selling out during the quarter.
  • Mazama Capital Management sold 564,952 Genesis Healthcare, Inc. shares in Q1 2016, an estimated $1.96M.
  • Mazama Capital Management first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 4 quarters.
  • Mazama Capital Management's Genesis Healthcare, Inc. position peaked at $2.65M in Q3 2015.
  • 71 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.